KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Cvs Health (CVS) over the last 16 years, with Q4 2025 value amounting to $103.6 billion.

  • Cvs Health's Other Operating Expenses rose 864.15% to $103.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $397.4 billion, marking a year-over-year increase of 908.99%. This contributed to the annual value of $397.4 billion for FY2025, which is 39750700.0% up from last year.
  • According to the latest figures from Q4 2025, Cvs Health's Other Operating Expenses is $103.6 billion, which was up 864.15% from $106.1 billion recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Other Operating Expenses registered a high of $106.1 billion during Q3 2025, and its lowest value of -$5.2 billion during Q3 2022.
  • In the last 4 years, Cvs Health's Other Operating Expenses had a median value of $88.2 billion in 2024 and averaged $68.4 billion.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 1257.64% in 2021, then tumbled by 10073.87% in 2022.
  • Cvs Health's Other Operating Expenses (Quarter) stood at $68.3 billion in 2021, then tumbled by 100.14% to -$99.0 million in 2022, then surged by 96405.05% to $95.3 billion in 2024, then rose by 8.64% to $103.6 billion in 2025.
  • Its last three reported values are $103.6 billion in Q4 2025, $106.1 billion for Q3 2025, and $96.5 billion during Q2 2025.